Jazz plans early July launch for sleepiness med Sunosi after DEA scheduling

Jazz Pharmaceuticals has had an FDA approval in hand for sleepiness med Sunosi for months, but now it can start planning its official rollout. On Monday, the Drug Enforcement Agency tagged the drug with a Schedule IV designation, setting Jazz up for a launch next month.